BioVaxys Announces Study On Modified Spike Protein In COVID-19 Vaccine To Reduce Risk Of Rare Side Effects
BioVaxys Technology Corp. (CSE: BIOV) announced this morning that it has initiated a study on the reduced ACE2 binding capabilities
Read more
Biotech
Pfizer-BioNTech COVID-19 Vaccine Trial For Ages 5-11 Returns Favorable Topline Results
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced this morning the topline results coming from its phase 2/3
Read more
BioVaxys Sees Manufacturing Partner Reach Bioproduction Milestone For Ovarian Cancer Vaccine
BioVaxys Technology Corp. (CSE: BIOV) announced this morning that its France-based manufacturing partner, Bio Elpida, has reached milestones in its
Read more
InMed To Acquire BayMedica In All-Stock Transaction Pegged At US$3.7 Million
InMed Pharmaceuticals (NASDAQ: INM) is looking to acquire one of its competitors. The firm has entered into a definitive agreement
Read more
CytoDyn Starts Phase 3 Trial Of Antibody Treatment For COVID-19 Patients With Severe Symptoms In Brazil
CytoDyn Inc. (OTCQB: CYDY) reported on Thursday night that it started a phase 3 clinical trial to consider the company’s
Read more
Cassava Sciences Answers Allegations Of Fraud: “We’re Not An Entertainment Company; We’re A Science Shop”
Cassava Sciences, Inc. (Nasdaq: SAVA) saught this morning to put an end to the allegations of fraud being made towards
Read more
Cronos Group, Ginkgo Bioworks Achieve Partnership Productivity Target For CBG Acid
Cronos Group, Inc. (TSX: CRON) and Ginkgo Bioworks announced this morning that its partnership has achieved the productivity target for
Read more
Revive Therapeutics Enters Exclusive License For Ganoderma Lucidum Intellectual Property
Revive Therapeutics (CSE: RVV) last night announced that it has has entered into an exclusive licensing agreement. The licensing agreement
Read more
Paul Andreola: ImmunoPrecise & Stock Picking In The Small Cap Arena – The Daily Dive
In this episode, we sat down with Paul Andreola, from Smallcap Discoveries, whom is also a director of ImmunoPrecise Antibodies
Read more
Antibe Therapeutics Pauses Otenaproxesul Trial After Exceeding Safety Threshold
Antibe Therapeutics Inc. (TSX: ATE) shared today that it is putting on pause the absorption, metabolism, and excretion study of
Read more